PAAB has developed a standardized request letter and response template to streamline consultation with Canadian authoritative medical bodies when evaluating consensus guidelines cited in drug advertising that may not meet requirements in code section 3.2 (see the guidance on what constitutes medical opinion). This service is intended to reduce administrative burden and friction for all parties by providing a clear, structured format for input on whether a reference aligns with current Canadian clinical practice.
By helping to facilitate timely access to expert perspectives, particularly in areas where formal national guidelines may be limited, PAAB helps ensure that advertising directed to health care professionals remains accurate, credible, and reflective of real-world Canadian medical opinion.
We appreciate your collaboration in supporting high standards for prescription drug communication in Canada. If you are unsure as to whether a guideline you are citing is acceptable for use in advertising, we encourage you to submit for a written opinion.
